Structure Therapeutics (GPCR) Insider Trading

Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Structure Therapeutics.

Bought (12 mo) $0
Sold (12 mo) $8,674,301
Insiders Buying (12 mo) 0
Insiders Selling (12 mo) 3
Form 4 Filings (All Time) 77
Most Recent Purchase
February 9, 2023
Melita Sun Jung Officer
$15,000
Most Recent Sale
September 22, 2026
Crespo Blas Coll Officer
$144,873
Buys (90d) 0
Sells (90d) 4
Recent Insider Transactions
Recent insider transactions
Filed Insider Role Type Value % Change
2026-09-22 Coll Crespo Blas Officer Sell $144,873 -8.1%
2026-09-03 Lin Xichen Officer Sell $278,661 —
2026-08-20 Lin Xichen Officer Sell $210,610 —
2026-08-07 Berrios John Joseph Officer Award — —
2026-08-05 Lin Xichen Officer Sell $194,760 —
Sign up free to view more insider trades.